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The Relationship Between Area Poverty Rate and Site-Specific
Cancer Incidence in the United States
Francis P. Boscoe, PhD1; Christopher J. Johnson, MPH2; Recinda L. Sherman, PhD3; David G. Stinchcomb, MS4;
Ge Lin, PhD5; and Kevin A. Henry, PhD6
BACKGROUND: The relationship between socioeconomic status and cancer incidence in the United States has not traditionally been
a focus of population-based cancer surveillance systems. METHODS: Nearly 3 million tumors diagnosed between 2005 and 2009
from 16 states plus Los Angeles were assigned into 1 of 4 groupings based on the poverty rate of the residential census tract at time
of diagnosis. The sex-specific risk ratio of the highest-to-lowest poverty category was measured using Poisson regression, adjusting
for age and race, for 39 cancer sites. RESULTS: For all sites combined, there was a negligible association between cancer incidence
and poverty; however, 32 of 39 cancer sites showed a significant association with poverty (14 positively associated and 18 negatively
associated). Nineteen of these sites had monotonic increases or decreases in risk across all 4 poverty categories. The sites most
strongly associated with higher poverty were Kaposi sarcoma, larynx, cervix, penis, and liver; those most strongly associated with
lower poverty were melanoma, thyroid, other nonepithelial skin, and testis. Sites associated with higher poverty had lower incidence
and higher mortality than those associated with lower poverty. CONCLUSIONS: These findings demonstrate the importance and rele-
vance of including a measure of socioeconomic status in national cancer surveillance. Cancer 2014;120:2191–8. VC 2014 The Authors.
Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of
the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided
the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
KEYWORDS: poverty, socioeconomic status, surveillance, incidence, health disparities.
INTRODUCTION
The ongoing monitoring of the relationship between socioeconomic status (SES) and health is an essential element of pub-
lic health surveillance. Most diseases and adverse health conditions exhibit an SES gradient, typically with those who are
poorer materially having higher morbidity and mortality.1,2 This gradient has been evident since at least the nineteenth
century and is true even in affluent countries and nations with social safety nets designed to limit absolute deprivation.3,4
For cancer, the picture is particularly complex, as access to health care, utilization of screening, and behavioral and occupa-
tional risk factors all exhibit strong influences on incidence rates and are simultaneously associated with SES. This associa-
tion results in SES gradients in cancer incidence in both directions, depending on the anatomic site. Sites associated with
lower SES in the United States include lung,5-7 colorectal,6-8 cervical,6,7,9 oral,10 and liver11 and those associated with
higher SES include breast,6,7,12 prostate,6,7,13 thyroid,14 and skin.6,15,16 Although these relationships are well-established,
they occupy a specialized niche in the literature and are rarely reported in standard population-based statistics. For exam-
ple, an interactive Web site published by the National Cancer Institute’s Surveillance, Epidemiology and End Results
(SEER) program features data by cancer site, age, sex, and race/ethnicity, but not SES.17 A similar Web site from the
North American Association of Central Cancer Registries (NAACCR) includes the same variables and adds state within
the United States.18 The most comprehensive review of SES and cancer in the United States remains the monograph by
Singh et al from 2003, but this covered only 6 cancer sites (breast, cervical, colorectal, lung, prostate, skin) and is now 10
years old.19 The relationships between SES and cancer incidence are dynamic, which highlights the need for ongoing
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surveillance. The most familiar example is lung cancer,
where incidence rates lag behind the shifting popularity
and social acceptability of smoking among different sec-
tors of the population.20
The ubiquity of race/ethnicity data, in contrast, has
led to a well-developed literature on racial/ethnic dispar-
ities in cancer that creates an impression that this is a more
relevant variable than SES. However, to the extent that
researchers have tried to disentangle these 2 concepts, SES
has proven more robust,21,22 even as some have argued
the 2 are so tightly interwoven as to be inseparable.23
Indeed, Penner and Saperstein found that 20% of the per-
sons in a long-term longitudinal study changed their racial
self-identification at least once, and the changes corre-
sponded to changes in SES.24
The shortage of SES reporting within cancer surveil-
lance is driven in part because it is rarely collected by pub-
lic health data systems. SES is collected by certain surveys,
but surveys are not an effective means of ascertaining can-
cer incidence, both because of the rarity of many cancers
and difficulties with accurate self-reporting for many ana-
tomic sites of cancer.25 Residential address is therefore
typically used as a proxy for SES in population-based can-
cer research. This is not as large a limitation as it may
seem at first glance. An area-based SES measures captures
conditions that affect all individuals living in the same
neighborhood and SES has been shown to be an independ-
ent predictor of health outcomes.26-28 Because of concerns
over patient confidentiality, SES assignment is most often
performed at the county level, which tends to be problem-
atic, particularly in large urban counties where populations
are highly heterogeneous. New York County (Manhattan)
is perhaps the most striking example, being classified in the
poorest grouping by all commonly used measures despite
containing some of the wealthiest neighborhoods in the
world. A similar pattern holds in Los Angeles County,
Cook County (Chicago), and Miami-Dade County in
Florida; just these 4 counties alone account for 1/16th of
the US population. County-level analysis has the effect of
diminishing or even reversing the apparent relationship
between SES and cancer incidence.29
Census tracts are defined by a partnership between
the US Census Bureau and local authorities prior to each
decennial census and are intended to include a relatively
homogeneous population group of approximately 4000
people. Thus, tract-level SES measures do not tend to
have the same heterogeneity issues as county-level SES
measures. Although neighborhood factors that impact
health do not necessarily follow predefined areal units,30
because tracts are intended to be homogeneous
populations, SES measures at the tract-level should mini-
mize this issue.
Here, we report on the results of an effort to bring
SES into the mainstream of cancer surveillance in the
United States, using the census-tract level poverty rate as
the measure of SES. Poverty rate is one of several meas-
ures, along with income, education, and occupational cat-
egory, often used to measure SES in US health studies.20
It was selected here as the sole SES indicator available. Be-
ginning in 2011, US registries were encouraged to assign a
code to each cancer diagnosis based on the poverty level of
the census tract of residence at the time of diagnosis, retro-
active to 1995. The code was intentionally simple, con-
sisting of 5 categories: poverty rates of< 5%, 5% to<
10%, 10% to< 20%, 20%, and unknown. One reason
for this simplicity was to ensure that an individual census
tract could not be identified based on the code, as some
registries consider the release of a census tract to poten-
tially enable individual identification when combined
with other available demographic and clinical informa-
tion. Each of the state and regional registries contributing
to national cancer statistics have multiple census tracts
that fall into each of the above categories. A second reason
for this choice of code values was to conform with recom-
mendations from prior research in this area.19,28,31 The
SES gradients presented here are, to our knowledge, the
most detailed published for the United States, in terms of
both the breadth of anatomic sites and geographic
coverage.
MATERIALS AND METHODS
Incidence and Mortality Data
We obtained cancer incidence data from NAACCR for
16 states (Arizona, Colorado, Connecticut, Florida, Geor-
gia, Hawaii, Idaho, Iowa, Louisiana, Minnesota, New
Hampshire, New Jersey, New York, Texas, Utah, West
Virginia) and Los Angeles County, California for diagno-
sis years 2005 through 2009. These areas cover 42% of
the US population, defined as the 50 states plus the Dis-
trict of Columbia, as measured by the 2010 census. Each
of these registries was certified by the NAACCR for data
completeness and timeliness at the gold or silver level for
these years.32 Each registry consented to the use of its data
for this project, and the project was reviewed and
approved by NAACCR’s Institutional Review Board.
Cancer mortality data for the same states were obtained
from SEER.33
The analysis included 2.9 million malignant tumors
categorized by age (5-year age groups 0-4 through 80-84,
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then 851), sex, race/ethnicity (white, black, American In-
dian/Alaska Native [AI/AN], Asian/Pacific Islander
[API], and Hispanic), poverty category, and anatomic site
(39 distinct sites and 3 site groupings). We included all
sites for which the SEER program has published Cancer
Stat Fact Sheets,34 plus several other sites of particular in-
terest. Together these accounted for 99.1% of all reported
malignant cancers. The number of tumors per site ranged
from approximately 2000 (vagina) to 436,000 (prostate).
Equivalent International Classification of Diseases for
Oncology, Third Edition (ICD-O-3) codes for the
included sites can be found on the SEER web site.35 The
HPV-related cancer category combined penis, vagina,
vulva, cervix, anus, and the oral cancer subsites nasophar-
ynx, oropharynx, hypopharynx, and tonsil. The tobacco-
related cancer category combined oral cavity and pharynx,
esophagus, larynx, lung and bronchus, and urinary blad-
der. The “all sites combined” category also included the
0.9% of cancers not counted in one of the site categories.
Populations
We used custom single-year sex and age-specific census-
tract level populations developed by Woods & Poole, Inc.
for the use of the SEER program. These populations used
the same 2000 census definitions as the geocoded cancer
cases but were informed by both the 2000 and 2010 cen-
suses. Among other advantages, these populations were
able to reflect a number of large, upscale retirement com-
munities that were constructed after 2000.
TheWoods & Poole populations did not include in-
formation on race/ethnicity. To obtain this, we applied
the census-tract level race/ethnicity proportions from the
2010 census (Summary File 1, Tables PCT12H-
PCT12O) to the Woods & Poole estimates, using a
2010-to-2000 census tract crosswalk obtained from Geo-
Lytics, Inc. The census tables contain 14 race/ethnicity
categories (white, black, AIAN, Asian, Native Hawaiian
or other Pacific Islander, multiple, and some other race,
each cross-tabulated by both Hispanic and non-His-
panic), which we consolidated into the same 5 categories
as the cases. To achieve this, all Hispanic groups were
combined into a single Hispanic category, Asians and
Native Hawaiians/Pacific Islanders were combined as
API, non-Hispanics of multiple race were assigned to 1 of
the 4 non-Hispanic groups based on the proportion of
these groups in each census tract, and non-Hispanics of
some other race were assigned to either AIAN or API
based on the proportion of these 2 groups in each census
tract. The latter choice was made because these persons
tend to have origins in Central and South Asia and
Central and South America. The multiple race and other
race groups represented a very small proportion of the
total population, 2.0% and 0.2%, respectively.
Poverty
All cases were geocoded by the individual registries to
2000 census tracts and a census tract poverty level was
assigned to each case based on the percentage of individu-
als living below the poverty level according to the 2005-
2009 American Community Survey (ACS). The poverty
categories used were< 5%, 5%-< 10%, 10%-< 20%,
and 20%. Approximately 3% of the cases did not have
census tracts and/or poverty levels assigned and were
excluded from the analysis. Geocoding rates tended to be
lower in states with larger shares of post office box or rural
route addresses, and also for cases diagnosed in 2008 and
2009, reflecting the fact that geocoding is an ongoing and
labor-intensive process. Sensitivity analyses were per-
formed excluding various state/year combinations with
poorer geocoding, but had no effect on the results at our
reported precision (data from this and subsequent sensi-
tivity analyses are not shown). For reasons of confidential-
ity protection, we did not have access to the actual census
tract for each patient.
We used the ACS 2005 to 2009 poverty variable
because it is the sole source of small-area poverty data that
corresponds to our study period. However, the 5-year
combined ACS sample is not as large as the 2000 census
long form, and has a larger margin of error for its point
estimates. We conducted sensitivity analyses comparing
results from error in covariates models for the ACS pov-
erty estimates with results from models that consider the
ACS poverty estimates to be known, and found the esti-
mates of risk to have 95% confidence intervals that were
nearly entirely overlapping. Furthermore, the potential
impact of SES misclassification due to ACS estimates is
ameliorated by our use of 4 poverty categories and by
grouping results for the entire study population. None-
theless, for individual census tracts, there may be sizable
differences between the actual poverty rate and that esti-
mated via the ACS given the high sampling error in the
ACS estimates.36
Cancer Rates
We calculated site- and sex-specific, age-adjusted rates
stratified by the 4 poverty categories, both stratifying and
adjusting for race/ethnicity. We determined whether a
monotonic increase or decrease in cancer rates was seen
across the 4 poverty categories by comparing the magni-
tude of the point estimates in each category for each site/
sex combination, and calculated the risk ratios of the
Poverty and Cancer Incidence in the USA/Boscoe et al
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highest to lowest poverty category. As a validity check, we
also tested for trend across the poverty categories using
Poisson regression. Once the cancer sites associated with
poverty were identified, we compared the age-adjusted
incidence and mortality rates for these groups of sites.
All cancer rate calculations were performed using
SEER*Stat (version 8.0.1). Statistical analysis was con-
ducted using R (version 3.0.0) and the SAS (version 9.3)
GLIMMIX procedure, and the error in covariates sensitiv-
ity analysis was conducted using WinBUGS; the code is
available from the authors by request.
RESULTS
Figure 1 presents the sex-specific risk ratios of the highest
to lowest residential poverty category for each cancer site.
A majority of cancer sites show a significant relationship
with poverty rate. Twenty-four of the 31 sites for which
there are data for both sexes have a 95% confidence inter-
val that excludes unity, as do all 8 of the sex-specific sites.
Fourteen of these 32 sites are associated with higher pov-
erty and 18 are associated with lower poverty. HPV and
tobacco-related cancers are also associated with higher
poverty. The sites most strongly associated with higher
poverty are Kaposi sarcoma, larynx, cervix, and penis;
those most strongly associated with lower poverty are mel-
anoma, thyroid, and other nonepithelial skin. Sites with
monotonic increases or decreases across all 4 poverty cate-
gories are indicated with symbols. Thirteen of the 31 sites
for which there are data for both sexes show monotonic
increases or decreases, along with 6 of the sex-specific sites.
Adjusting for age and race, cancer incidence differed sig-
nificantly by poverty category for nearly all sex-site combi-
nations; the only exceptions were bone and joint, eye and
orbit among females, and nasal cavity among females.
This analysis included instances where the relationship
between poverty and incidence was not monotonic, and
the interpretation of such patterns may be less clear.
For all sites and both sexes combined, the difference
in risk between the greatest and lowest poverty category is
less than 2%, suggesting that the individual site-specific
risks effectively cancel one another out. The sites that are
associated with higher poverty, however, tend to be much
more lethal. These sites have an age-adjusted incidence of
159.1 per 100,000 and age-adjusted mortality of 107.7
per 100,000 for diagnosis years 2005 to 2009. The sites
associated with lower poverty have an incidence rate of
260.3 per 100,000 and a mortality rate of 68.9. These fig-
ures exclude the rare sites Kaposi sarcoma and mesothe-
lioma, which were not included in our source of mortality
data.33
On the whole, male rates were more sensitive to pov-
erty level than female rates: of the 7 sites for which males
and females have nonoverlapping confidence intervals
(liver and interhepatic bile duct, miscellaneous, lung and
bronchus, anus, colon and rectum, oral cavity and phar-
ynx, kidney), males have the higher risk for all but kidney.
This finding is also evidenced by the slight differences
between sexes for all sites combined.
The above findings are net of any race/ethnicity
effects. Race/ethnicity-stratified results further illustrate
that poverty is an independent predictor of cancer inci-
dence. This relationship is seen in Figure 2, which con-
trasts differences between blacks and whites for 4 cancer
sites. In general, although the race-specific incidence rates
tend to differ, the poverty gradients are similar. For mela-
noma in particular, a site for which there is a biological
component driving differences between race groups, there
is about a 20-fold difference in rates between whites and
blacks, but the relationship between poverty and inci-
dence remains. Hodgkin lymphoma, in contrast, is nota-
ble because the poverty gradients do differ by race.
DISCUSSION
We have presented what is to our knowledge the most
comprehensive assessment of the relationship between
SES and cancer incidence for the United States. There is a
negligible relationship between local poverty rate and can-
cer incidence overall, but 32 of 39 individual cancer sites
show such an association, with 14 sites associated with
higher poverty and 18 sites associated with lower poverty.
This includes 19 sites with stronger evidence of a relation-
ship as indicated by a monotonic increase or decrease
across all 4 poverty categories. The combined categories
of HPV-associated and tobacco-associated cancers also are
positively associated with poverty.
In general, cancer sites associated with behavioral
risk factors such as tobacco, alcohol and intravenous drug
use, sexual transmission, and poor diet tend to be associ-
ated with higher poverty. In contrast, cancer sites associ-
ated with overdiagnosis are associated with lower poverty,
notably skin, thyroid, and prostate. Overdiagnosis refers
to the clinical detection of asymptomatic tumors, often
through advanced medical technology, that would other-
wise remain undetected and uncounted. Many of these
relationships are well established, but others have received
limited attention because of their rarity, and others have
been obscured as a consequence of using county as the
level of analysis. For example, Jemal et al reported “no
striking socioeconomic status disparities” for HPV-
associated cancers beyond cervical, penile and anal among
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men,37 whereas in the current study using census tract
poverty measures such a relationship is seen for every
HPV-related site.
Our results are consistent with those reported by
Clegg et al,6 who used individual-level poverty as obtained
through the National Longitudinal Mortality Study.
The point estimates of the high-to-low poverty category
risk ratios reported here agree within 1 decimal place for
lung, colorectal, prostate, breast, and melanoma, which is
all the more remarkable considering their study contained
less than 1/200th the number of cases for comparable
sites. The only possible exception was for cervix where the
Figure 1. Risk ratios of cancer incidence between highest and lowest poverty category, United States, 2005 through 2009. IBD
indicates inflammatory bowel disease.
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results from Clegg et al suggest a stronger poverty gradi-
ent, though based on only 116 cases.6 Although individ-
ual and area SES are widely accepted as representing
different dimensions of risk,26,27 in the case of cancer inci-
dence this difference may be less critical. If so, the design
of the present study has the advantage of using
population-based data collected as part of ongoing, rou-
tine cancer surveillance that does not require contacting
patients or linking to individual-level surveys.
The SES effects we report are independent of race, as
race was adjusted for in the analysis. This is further illus-
trated by the graph of race-stratified results for selected
sites (Fig. 2). To our knowledge, race-specific poverty gra-
dients for melanoma have not previously been reported
because of the rarity of this disease among nonwhites;
more commonly, melanoma reporting is restricted to
white non-Hispanics.6,15,16 More detailed analysis of
race-stratified results will be the focus of future work,
building on other research that has consistently found in-
dependent race and SES effects in cancer incidence.38-40
Although use of the official US government–defined
poverty rate has a long history in the field of cancer epide-
miology, it does have many critics, who focus on its failure
to incorporate noncash income, among many other
Figure 2. Race-specific cancer rates by poverty category, non-Hispanic whites and non-Hispanic blacks, both sexes combined
except for prostate. (A) Lung and bronchus, (B) prostate, (C) melanoma, and (D) Hodgkin lymphoma. For (C), a logarithmic scale
was used for clarity, and confidence intervals for non-Hispanic whites were smaller than the point symbol used.
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issues.41 There could very well exist an alternative measure
of poverty or deprivation that would reveal a clearer rela-
tionship with cancer. However, because many of the prob-
lems with poverty definition and measurement would
likely result in random misclassification, any bias in our
results should be toward the null. A further limitation is
that because we did not know the identities of the census
tracts, only their poverty categories, we were unable to
add spatial effects to our models. Disease rates in areas
that are geographically proximate are often correlated,
and spatially correlated observations do not satisfy the
assumption of independence. Ignored, residual spatial
correlation may bias estimates of parameters and lead to
underestimated standard errors.42 However, because we
aggregated data by poverty category over the states in the
study, this limitation is not as likely to be relevant than
had we used census tract as the unit of analysis. Informa-
tion on the specific behavioral risk factors (smoking, HPV
status, and so forth) of each cancer patient would have
informed our results, but such information is not typically
collected by central cancer registries.
In addition to the race-specific analysis mentioned
above, we also intend to investigate SES gradients by
stage at diagnosis. For a site with a positive screening
effect such as colorectal cancer, we might reasonably
hypothesize that earlier stage cancers would be less
associated with higher poverty than later stage cancers,
because access to and use of health care is itself related
to SES. We also intend to investigate the extent to
which the cancer-SES relationships vary meaningfully
between states. Because NAACCR has elevated the
census tract poverty indicator to a required, as opposed
to optional, data item for central cancer registries
beginning with cases diagnosed in 2014, the number
of states available for analysis is expected to grow
appreciably. This action will help ensure that data on
SES will be more readily available to researchers in US
cancer surveillance data sources.
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